SEQUENCE THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS ... SEQUENCE THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
モノクロメーター: Single crystal Si(111) bent (horizontal focusing) プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray
放射波長
波長: 0.97912 Å / 相対比: 1
反射
解像度: 1.7→29.854 Å / Num. obs: 65104 / % possible obs: 99.2 % / 冗長度: 5 % / Biso Wilson estimate: 16.3 Å2 / Rmerge(I) obs: 0.107 / Rsym value: 0.107 / Net I/σ(I): 5.9
反射 シェル
Diffraction-ID: 1
解像度 (Å)
冗長度 (%)
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured all
Num. unique all
Rsym value
% possible all
1.7-1.74
5
0.716
1.1
23099
4642
0.716
96.6
1.74-1.79
5
0.611
1.3
22497
4540
0.611
97.1
1.79-1.84
5
0.468
1.6
22059
4451
0.468
97.9
1.84-1.9
4.9
0.376
2
21524
4349
0.376
98.4
1.9-1.96
5
0.313
2.4
21102
4255
0.313
98.9
1.96-2.03
5
0.251
3
20504
4114
0.251
99.6
2.03-2.11
5
0.204
3.7
20100
4035
0.204
99.9
2.11-2.19
5
0.175
4.2
19391
3877
0.175
100
2.19-2.29
5
0.148
5
18637
3711
0.148
100
2.29-2.4
5
0.137
5.3
17802
3544
0.137
100
2.4-2.53
5
0.125
5.8
17150
3416
0.125
100
2.53-2.69
5
0.114
6.1
16133
3213
0.114
100
2.69-2.87
5
0.104
6.6
15106
3017
0.104
100
2.87-3.1
5
0.086
7.8
14190
2841
0.086
100
3.1-3.4
5
0.07
9.4
12925
2593
0.07
100
3.4-3.8
5
0.059
11.2
11774
2377
0.059
100
3.8-4.39
4.9
0.052
12.5
10420
2121
0.052
100
4.39-5.38
4.8
0.05
13
8656
1789
0.05
100
5.38-7.6
4.7
0.057
11.7
6558
1410
0.057
100
7.6-29.854
4.3
0.05
12.4
3477
809
0.05
98.4
-
位相決定
位相決定
手法: 単波長異常分散
-
解析
ソフトウェア
名称
バージョン
分類
NB
REFMAC
5.4.0067
精密化
PHENIX
精密化
SHELX
位相決定
MolProbity
3beta29
モデル構築
SCALA
データスケーリング
PDB_EXTRACT
3
データ抽出
MAR345
CCD
データ収集
MOSFLM
データ削減
SHELXD
位相決定
autoSHARP
位相決定
精密化
構造決定の手法: 単波長異常分散 / 解像度: 1.7→29.854 Å / Cor.coef. Fo:Fc: 0.975 / Cor.coef. Fo:Fc free: 0.961 / SU B: 3.506 / SU ML: 0.058 / TLS residual ADP flag: LIKELY RESIDUAL / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.084 / ESU R Free: 0.085 立体化学のターゲット値: MAXIMUM LIKELIHOOD WITH PHASES 詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN ...詳細: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4. CL IONS, EDO, AND PEG 8000 (PG4) FROM THE CRYSTALLIZATION/CRYO SOLUTIONS ARE MODELED.
Rfactor
反射数
%反射
Selection details
Rfree
0.169
3297
5.1 %
RANDOM
Rwork
0.138
-
-
-
obs
0.139
65081
99.05 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: BABINET MODEL WITH MASK